Arylsulfatase E anticorps (AA 504-553)

N° du produit ABIN6756625

Détail du produit anti-Arylsulfatase E anticorps

Antigène: Arylsulfatase E (ARSE)

Épitope: AA 504-553

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Arylsulfatase E est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Marque: IHC-plus™

Specificité: Human ARSE

Purification: Immunoaffinity purified

Immunogène: Synthetic peptide located between aa504-553 of human ARSE (P51690, NP_000038). Percent identity by BLAST analysis: Human, Gorilla, Gibbon (100%), Monkey (92%).

Type of Immunogen: Synthetic peptide

Isotype: IgG

Information d'application

Indications d'application: Approved: IHC, IHC-P (10 μg/mL), WB (0.2 - 1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:62500.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Distilled water

Concentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Conseil sur la manipulation: Avoid repeat freeze-thaw cycles.

Stock: 4 °C,-20 °C

Stockage commentaire: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Détails sur Arylsulfatase E

Antigène: Arylsulfatase E (ARSE)

Autre désignation: ARSE / Arylsulfatase E (ARSE Produits)

Synonymes: anticorps ASE, anticorps CDPX, anticorps CDPX1, anticorps CDPXR, anticorps ARSE, anticorps MGC155058, anticorps arylsulfatase E (chondrodysplasia punctata 1), anticorps arylsulfatase E, anticorps ARSE, anticorps Arse

Sujet: Name/Gene ID: ARSE

Synonyms: ARSE, Arylsulfatase E, ASE, CDPX, CDPXR, CDPX1, Chondrodysplasia punctata 1

ID gène: 415

NCBI Accession: NP_000038